TriDerma is recalling about 410 units of Pain Relief Cream with 4% Lidocaine (lidocaine topical) because the packaging fails to meet child-resistant safety requirements. This cream contains lidocaine, which can be dangerous if young children accidentally ingest it or apply it to their skin. The affected products include a 4-ounce jar and a 2.2-ounce tube sold online between January 2018 and April 2019. TriDerma is providing free child-resistant replacement caps to affected consumers.
The current packaging lacks a child-resistant closure, allowing young children to easily access the lidocaine cream. If a child ingests or absorbs a significant amount of lidocaine through their skin, it poses a serious risk of poisoning.
Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a free replacement child-resistant cap. TriDerma is contacting all known purchasers directly.
Recalled TriDerma Pain Relief Cream with Lidocaine in 4 ounce jar
Recalled TriDerma Pain Relief Cream with Lidocaine in 2.2 ounce tube
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: CPSC Notice · Raw API Response